• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INNOVA; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INNOVA; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number 26921
Device Problems Activation, Positioning or Separation Problem (2906); Migration (4003)
Patient Problem Insufficient Information (4580)
Event Date 10/12/2021
Event Type  Injury  
Event Description
It was reported that the stent partially deployed and a dislodgement occurred.After opening the superficial femoral artery, the patient developed a dissection.A 6 x 150 x 130 innova was selected for use.During the procedure, the stent did not fully deploy and there was intravascular drag and stretch.The stent dislodged.A non-boston scientific stent was deployed to cover and overlap the innova stent.There were no patient complications reported and the patient's status was stable.
 
Manufacturer Narrative
(b)(6).
 
Manufacturer Narrative
Initial reporter facility name: (b)(6) hospital.
 
Event Description
It was reported that the stent partially deployed and a dislodgement occurred.After opening the superficial femoral artery, the patient developed a dissection.A 6 x 150 x 130 innova was selected for use.During the procedure, the stent did not fully deploy and there was intravascular drag and stretch.The stent dislodged.A non-boston scientific stent was deployed to cover and overlap the innova stent.There were no patient complications reported and the patient's status was stable.It was further reported that vascular access was obtained via the contralateral common femoral artery, through the common iliac artery, the other common iliac artery, the other common femoral artery, finally reaching the superficial femoral artery (sfa).The more than 95 percent stenosed target lesion was located in the mildly tortuous and moderately calcified sfa.The lesion was pre-dilated.High force was required to turn the thumbwheel.The whole stent deployed; however after deployment, the stent was stretched.
 
Manufacturer Narrative
E1: initial reporter facility name: (b)(6) hospital.Device evaluated by mfr: the product was returned to boston scientific for analysis.Returned product consisted of an innova sds.The outer sheath, tip and the remainder of the device were checked for damage.The catheter shaft showed a kink at the nosecone.The middle sheath showed no damage.The inner liner was extended to the maximum position with no damage.The stent was not returned in the device.The pull handle was at its farthest position.X-ray of the device showed no internal damage.No other damage was noticed.Inspection of the remainder of the device, apart from the observed issue, revealed no other issues or irregularities.
 
Event Description
It was reported that the stent partially deployed and a dislodgement occurred.After opening the superficial femoral artery, the patient developed a dissection.A 6 x 150 x 130 innova was selected for use.During the procedure, the stent did not fully deploy and there was intravascular drag and stretch.The stent dislodged.A non-boston scientific stent was deployed to cover and overlap the innova stent.There were no patient complications reported and the patient's status was stable.It was further reported that vascular access was obtained via the contralateral common femoral artery, through the common iliac artery, the other common iliac artery, the other common femoral artery, finally reaching the superficial femoral artery (sfa).The more than 95 percent stenosed target lesion was located in the mildly tortuous and moderately calcified sfa.The lesion was pre-dilated.High force was required to turn the thumbwheel.The whole stent deployed; however after deployment, the stent was stretched.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INNOVA
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key12795219
MDR Text Key280691199
Report Number2134265-2021-13905
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 12/16/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/04/2024
Device Model Number26921
Device Catalogue Number26921
Device Lot Number0026918105
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/30/2021
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/01/2021
Initial Date FDA Received11/11/2021
Supplement Dates Manufacturer Received11/09/2021
12/02/2021
Supplement Dates FDA Received12/01/2021
12/16/2021
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/05/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age72 YR
Patient SexMale
Patient Weight79 KG
-
-